Camilla Jessen
A popular over-the-counter flu medication is being pulled from shelves.
Others are reading now
More than 14,000 boxes of a widely sold cold and flu medication have been recalled nationwide due to packaging that fails to meet federal child safety standards, the U.S. Consumer Product Safety Commission (CPSC) announced.
The recall affects Safetussin Max Strength Multi-Symptom Cough, Cold and Flu caplets—specifically, the 24-count blister packs sold between July 2024 and March 2025.
The medicine, packaged in blue, orange, and red boxes, was distributed to major grocery chains and pharmacies across the U.S., including HEB and Harris Teeter, with an average retail price of around $11.
Why the Recall Matters
At the center of the recall is a violation of the Poison Prevention Packaging Act, which requires child-resistant features on packaging for medications containing potentially harmful substances like acetaminophen.
The CPSC warns that the current blister packaging can be easily punctured, making it possible for young children to access and ingest the tablets.
“The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children,” the CPSC stated.
Consumers who have purchased the recalled medication are advised to stop using it immediately and either dispose of it safely or return it to the place of purchase for a full refund.